These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12971423)

  • 1. What is the role of medium-chain triglycerides in the management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency?
    Lund AM; Dixon MA; Vreken P; Leonard JV; Morris AA
    J Inherit Metab Dis; 2003; 26(4):353-60. PubMed ID: 12971423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
    MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S
    J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.
    Gillingham MB; Scott B; Elliott D; Harding CO
    Mol Genet Metab; 2006; 89(1-2):58-63. PubMed ID: 16876451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Gillingham MB; Connor WE; Matern D; Rinaldo P; Burlingame T; Meeuws K; Harding CO
    Mol Genet Metab; 2003 Jun; 79(2):114-23. PubMed ID: 12809642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome?
    Holub M; Bodamer OA; Item C; Mühl A; Pollak A; Stöckler-Ipsiroglu S
    Acta Paediatr; 2005 Jan; 94(1):48-52. PubMed ID: 15858960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency--diagnosis, plasma carnitine fractions and management in a further patient.
    Moore R; Glasgow JF; Bingham MA; Dodge JA; Pollitt RJ; Olpin SE; Middleton B; Carpenter K
    Eur J Pediatr; 1993 May; 152(5):433-6. PubMed ID: 8319713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Newborn Screening and Early Dietary Management on Clinical Outcome of Patients with Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency and Medium Chain Acyl-CoA Dehydrogenase Deficiency-A Retrospective Nationwide Study.
    Rücklová K; Hrubá E; Pavlíková M; Hanák P; Farolfi M; Chrastina P; Vlášková H; Kousal B; Smolka V; Foltenová H; Adam T; Friedecký D; Ješina P; Zeman J; Kožich V; Honzík T
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative measurement of total and free 3-hydroxy fatty acids in serum or plasma samples: short-chain 3-hydroxy fatty acids are not esterified.
    Jones PM; Burlina AB; Bennett MJ
    J Inherit Metab Dis; 2000 Nov; 23(7):745-50. PubMed ID: 11117435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased and early lipolysis in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency during fast.
    Haglind CB; Nordenström A; Ask S; von Döbeln U; Gustafsson J; Stenlid MH
    J Inherit Metab Dis; 2015 Mar; 38(2):315-22. PubMed ID: 25141826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupted fat distribution and composition due to medium-chain triglycerides in mice with a β-oxidation defect.
    Tucci S; Flögel U; Sturm M; Borsch E; Spiekerkoetter U
    Am J Clin Nutr; 2011 Aug; 94(2):439-49. PubMed ID: 21697078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.
    Shen JJ; Matern D; Millington DS; Hillman S; Feezor MD; Bennett MJ; Qumsiyeh M; Kahler SG; Chen YT; Van Hove JL
    J Inherit Metab Dis; 2000 Feb; 23(1):27-44. PubMed ID: 10682306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of a patient with a kinetic variant of medium and short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency by newborn screening.
    Vilarinho L; Marques JS; Rocha H; Ramos A; Lopes L; Narayan SB; Bennett MJ
    Mol Genet Metab; 2012 Jul; 106(3):277-80. PubMed ID: 22579592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urgent metabolic service improves survival in long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot newborn screening.
    Sykut-Cegielska J; Gradowska W; Piekutowska-Abramczuk D; Andresen BS; Olsen RK; Ołtarzewski M; Pronicki M; Pajdowska M; Bogdańska A; Jabłońska E; Radomyska B; Kuśmierska K; Krajewska-Walasek M; Gregersen N; Pronicka E
    J Inherit Metab Dis; 2011 Feb; 34(1):185-95. PubMed ID: 21103935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians.
    Potter BK; Little J; Chakraborty P; Kronick JB; Evans J; Frei J; Sutherland SC; Wilson K; Wilson BJ
    J Inherit Metab Dis; 2012 Jan; 35(1):115-23. PubMed ID: 21630065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey.
    Gillingham M; Van Calcar S; Ney D; Wolff J; Harding C
    J Inherit Metab Dis; 1999 Apr; 22(2):123-31. PubMed ID: 10234607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a long-chain triglyceride-restricted/medium-chain triglyceride-supplemented diet in a case of malonyl-CoA decarboxylase deficiency with cardiomyopathy.
    Footitt EJ; Stafford J; Dixon M; Burch M; Jakobs C; Salomons GS; Cleary MA
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S253-6. PubMed ID: 20549361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of odd-numbered medium-chain fatty acids on the accumulation of long-chain 3-hydroxy-fatty acids in long-chain L-3-hydroxyacyl CoA dehydrogenase and mitochondrial trifunctional protein deficient skin fibroblasts.
    Jones PM; Butt YM; Bennett MJ
    Mol Genet Metab; 2004 Feb; 81(2):96-9. PubMed ID: 14741189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.
    Jones PM; Butt Y; Bennett MJ
    Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD).
    Karall D; Brunner-Krainz M; Kogelnig K; Konstantopoulou V; Maier EM; Möslinger D; Plecko B; Sperl W; Volkmar B; Scholl-Bürgi S
    Orphanet J Rare Dis; 2015 Feb; 10():21. PubMed ID: 25888220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.